This message contains images. If you don't see images, click here to view. Click
here to advertise in this news brief.
|
|
|
|
A New Year for the AST
AST
In his first blog as president, Dr. James Allan thanks the outgoing AST leaders and welcomes the new leadership as he highlights AST initiatives for the year ahead. Read more from Dr. Allan’s first blog post to see where the AST is headed. What would you like to see the AST accomplish this year? Let us know what you think in the blog’s comment section.
|
|
Share this article:
    |
|
|
New AST President and Board Members
AST
The AST announced James Allan, M.D., MBA, as president, and Anil Chandraker, M.D., as president-elect. They are joined by Ronald Gill, PhD, as secretary, and four new councilors-at-large: John Gill, M.D., MS; Deepali Kumar, M.D.; Jesse Schold, Ph.D., M Stat, MEd.; and Alexander Wiseman, M.D. Read more about the new board.
AST Achievement Awards and Grants
AST
The AST announced this year's Achievement Award and Grant recipients at the recent American Transplant Congress. Read more to learn about the winners.
PRODUCT SHOWCASE
 |
|
You care about your transplant
patients. And so do we. That’s
why we’re introducing Astellas
Cares—a new program that
offers you customized tools,
educational resources, and
comprehensive support to help
your patients care for their
health. To register, visit
AstellasCares.com/Transplant
today.
|
|
AST Lifetime Achievement Award
AST
The AST awarded its highest honor, the Lifetime Achievement Award, to Donald Hricik, M.D., at the recent American Transplant Congress. This award honors a senior investigator whose lifelong work has advanced the field of transplantation. Read more about the award.
ATC 2016 Program submission available
AST
The 2016 American Transplant Congress Program Planning Committee is now accepting program proposals for scientific sessions to be held June 11-15, 2016 in Boston, Massachusetts. Participate in the Call for Programs and share your experience and knowledge with leaders in the transplantation community from across the globe. The deadline to submit proposals is June 5, 2015.
PRODUCT SHOWCASE
 |
|
The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
|
|
Education and Clinical Tools for the Independent Living Donor Advocate: A new webinar series
AST
The AST Live Donor Community of Practice announces the Education and Clinical Tools for the Independent Living Donor Advocate (ILDA) webinar series. This nine-part series starts on May 27 and runs through December, offering valuable resources for ILDAs. The entire series is free to AST members and their associates, just register with an AST member username and password at www.myAST.org/ILDA.
Non-members can purchase access to all nine webinars for just $200. Eligible non-members can join AST as a non-doctoral member and the webinar series is included in their $90 annual dues. Find out more at www.myAST.org/ILDA.
Update on hepatitis C eradication: Webinar May 19
AST
Register today for the final webinar in AST's 2014-2015 Timely Topics in Transplantation series, "Update on Hepatitis C Eradication Including Renal Clearance and Dosing and Important DDI Highlights." Presented by Kimberly Brown, M.D., and Tiffany Kaiser, PharmD, this webinar focuses on emerging therapies for HCV in transplant patients with specific attention to drug-drug interactions and limitations in patients with renal disease.
PRODUCT SHOWCASE
 |
|
VTI’s disposable intraoperative Doppler probes are ready to verify technical results.
There’s no longer the need to perform sterilization that frequently causes irreversible damage to the traditional Doppler probes.
Advantages include fewer replacements of conventional Doppler probes damaged during sterilization, OR time saved, and a reduction in specialty procedures.
|
|
Assessing antibody strength: Comparison of MFI, C1q, and titer information
American Journal of Transplantation
The presence of donor-specific HLA antibodies before or after transplantation may have different implications based on the antibody strength. Yet, current approaches do not provide information regarding the true antibody strength as defined by antigen–antibody dissociation rate. To assess currently available methods, we compared between neat mean fluorescence intensity (MFI) values, C1q MFI values, ethylenediaminetetraacetic acid (EDTA)-treated samples, as well as titration studies and peak MFI values of over 7000 Luminex-based single-antigen HLA antibody data points.
Reassessing medical risk in living kidney donors
Journal of the American Society of Nephrology
The short- and long-term effects of unilateral nephrectomy on living donors have been important considerations for 60 years. Short-term risk is well established (0.03 percent mortality and less than 1 percent risk of major morbidity), but characterization of long-term risk is evolving. Relative to the general population, risk of mortality, ESRD, hypertension, proteinuria, and cardiovascular disease is comparable or lower.
|
Raptor's mission is to develop and commercialize life-altering therapeutics that treat rare, debilitating, and often fatal diseases.
LEARN MORE
|
|
To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|